The effect of oncoprotein v-erbA on thyroid hormone-regulated genes in hepatocytes and their potential role in hepatocellular carcinoma

Molecular Biology Reports

Volumn 38, Issue 2, 2011, Pages 1137-1144

  Ventura Holman, Tereza ^b   Mamoon, Abulkhair ^b   Subauste, Maria C ^c   Subauste, Jose S ^a,b  

^a G V SONNY MONTGOMERY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Gene regulation; Microarrays; Thyroid hormone receptor; v erbA

Indexed keywords

LIOTHYRONINE; ONCOPROTEIN; THYROID HORMONE RECEPTOR;

ACTIVIN BETA C GENE; ANGIOPOIETIN 1 GENE; ANIMAL CELL; ARTICLE; CELL STRAIN; CELL STRAIN AML12; CONTROLLED STUDY; FOLLISTATIN GENE; GENE; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; IGFR2 GENE; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; NDRG2 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; RASGRP3 GENE; SIX1 GENE; THROMBOMODULIN GENE; UNINDEXED SEQUENCE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; GENES, ERBA; LIVER NEOPLASMS; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS; ONCOGENE PROTEINS V-ERBA; RECEPTORS, THYROID HORMONE; THYROID HORMONES; TIME FACTORS;

MURINAE; MUS MUSCULUS;

EID: 79951580472     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0211-2     Document Type: Article

References (31)

1. KH Lin HY Shieh SL Chen, et al. 1999 Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells Mol Carcinog 26 53 61 1:CAS:528:DyaK1MXmtVSkurs%3D 10.1002/(SICI)1098-2744(199909)26:1<53::AID- MC7>3.0.CO;2-Z 10487522 (Pubitemid 29420186)
2. Y Kamiya M Puzianowska-Kuznicka P McPhie, et al. 2002 Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma Carcinogenesis 23 25 33 1:CAS:528:DC%2BD38XptFSktg%3D%3D 10.1093/carcin/23.1.25 11756220 (Pubitemid 34213548)
3. M Puzianowska-Kuznicka A Krystyniak A Madej, et al. 2002 Functionally impaired TR mutants are present in thyroid papillary cancer J Clin Endocrinol Metab 87 1120 1128 1:CAS:528:DC%2BD38XitlWgtLg%3D 10.1210/jc.87.3.1120 11889175 (Pubitemid 36121076)
4. CS Wang KH Lin YC Hsu 2002 Alterations of thyroid hormone receptor alpha gene: frequency and association with Nm23 protein expression and metastasis in gastric cancer Cancer Lett 175 121 127 1:CAS:528:DC%2BD3MXovF2jurc%3D 10.1016/S0304-3835(01)00722-4 11741739 (Pubitemid 34001709)
5. LE Rietveld E Caldenhoven HG Stunnenberg 2001 Avian erythroleukemia: a model for corepressor function in cancer Oncogene 20 3100 3109 1:CAS:528:DC%2BD3MXks1GlurY%3D 10.1038/sj.onc.1204335 11420726 (Pubitemid 32553565)
6. C Barlow B Meister M Lardelli, et al. 1994 Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA EMBO J 13 4241 4250 1:CAS:528:DyaK2cXmsFakt7s%3D 7925269 (Pubitemid 24295196)
7. T Ventura-Holman A Mamoon JF Maher, et al. 2007 Thyroid hormone responsive genes in the murine hepatocyte cell line AML 12 Gene 396 332 337 1:CAS:528:DC%2BD2sXmvVentb0%3D 10.1016/j.gene.2007.04.005 17532580 (Pubitemid 46935406)
8. JC Wu G Merlino N Fausto 1994 Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor α Proc Natl Acad Sci USA 91 674 678 1:CAS:528:DyaK2cXhsFyjsL8%3D 10.1073/pnas.91.2.674 7904757 (Pubitemid 24041464)
9. RH Pierce JS Campbell AB Stephenson, et al. 2000 Disruption of redox homeostasis in TNF-induced apoptosis in a murine hepatocyte cell line Am J Pathol 157 221 236 1:CAS:528:DC%2BD3cXlsVGmt7c%3D 10880392 (Pubitemid 30641739)
10. YY Sautin JM Crawford SI Svetlov 2001 Enhancement of survival by LPA via Erk1/Erk2 and PI 3-kinase/Akt pathways in a murine hepatocyte cell line Am J Physiol Cell Physiol 281 C2010 C2019 1:CAS:528:DC%2BD3MXptlKmsLg%3D 11698260
11. OA Sukocheva DO Carpenter 2006 Anti-apoptotic effects of 3,5,3′-tri-iodothyronine in mouse hepatocytes J Endocrinol 191 447 458 1:CAS:528:DC%2BD28XhtlejsL3E 10.1677/joe.1.07061 17088414 (Pubitemid 44830620)
12. T Ventura-Holman A Mamoon JS Subauste 2008 Modulation of expression of RA regulated genes by the oncoprotein v-erbA Gene 425 23 27 1:CAS:528: DC%2BD1cXhtF2ntLjK 10.1016/j.gene.2008.08.006 18775481
13. C Bresson C Keime C Faure, et al. 2007 Large-scale analysis by SAGE reveals new mechanisms of v-erbA oncogene action BMC Genomics 8 390 10.1186/1471-2164-8-390 17961265
14. A Deli E Kreidl S Santifaller, et al. 2008 Activins and activin antagonists in hepatocellular Carcinoma World J Gastroenterol 14 1699 1709 1:CAS:528:DC%2BD1cXlsVelu7g%3D 10.3748/wjg.14.1699 18350601 (Pubitemid 351493376)
15. W Rossmanith M Chabicovsky B Grasl-Kraupp, et al. 2002 Follistatin overexpression in rodent liver tumors: a possible mechanism to overcome activin growth control Mol Carcinog 35 1 5 1:CAS:528:DC%2BD38XntVyhtr0%3D 10.1002/mc.10068 12203361 (Pubitemid 34988415)
16. M Grusch C Drucker B Peter-Vorosmarty, et al. 2006 Deregulation of the activin/follistatin system in hepatocarcinogenesis J Hepatol 45 673 680 1:CAS:528:DC%2BD28XhtVWqtr%2FE 10.1016/j.jhep.2006.06.014 16935389 (Pubitemid 44466665)
17. MF Yuen S Norris LW Evans, et al. 2002 Transforming growth factor-beta 1, activin and follistatin in patients with hepatocellular carcinoma and patients with alcoholic cirrhosis Scand J Gastroenterol 37 233 238 1:CAS:528: DC%2BD38XitFOmsbY%3D 10.1080/003655202753416939 11843063 (Pubitemid 34102262)
18. M Chabicovsky K Herkner W Rossmanith 2003 Overexpression of activin beta(C) or activin beta(E) in the mouse liver inhibits regenerative deoxyribonucleic acid synthesis of hepatic cells Endocrinology 144 3497 3504 1:CAS:528:DC%2BD3sXlslGjtrk%3D 10.1210/en.2003-0388 12865331 (Pubitemid 36904428)
19. S Vejda N Erlach B Peter, et al. 2003 Expression of activins C and E induces apoptosis in human and rat hepatoma cells Carcinogenesis 24 1801 1809 1:CAS:528:DC%2BD3sXovVeksL4%3D 10.1093/carcin/bgg154 12949049 (Pubitemid 37408144)
20. Y Yu J Khan C Khanna, et al. 2004 Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1as key metastatic regulators Nat Med 10 175 181 1:CAS:528:DC%2BD2cXoslKntQ%3D%3D 10.1038/nm966 14704789 (Pubitemid 38524888)
21. HL Ford EN Kabingu EA Bump, et al. 1998 Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis Proc Natl Acad Sci USA 95 12608 12613 1:CAS:528: DyaK1cXmsl2qtbw%3D 10.1073/pnas.95.21.12608 9770533 (Pubitemid 28483812)
22. Y Morikawa A Morikawa I Makino 1993 Relationship of thyroid states and serum thrombomodulin (TM) levels in patients with Graves' disease: TM, a possible new marker of the peripheral activity of thyroid hormones J Clin Endocrinol Metabol 76 609 614 1:STN:280:DyaK3s7os12ruw%3D%3D 10.1210/jc.76.3.609 (Pubitemid 23086474)
23. S Iino K Abeyama K Kawahara, et al. 2004 The antimetastatic role of thrombomodulin expression in islet cell-derived tumors and its diagnostic value Clin Cancer Res 10 6179 6188 1:CAS:528:DC%2BD2cXnvVOjs7k%3D 10.1158/1078-0432. CCR-03-0750 15448005 (Pubitemid 39287524)
24. DM Roberts AL Anderson M Hidaka, et al. 2004 A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters Mol Cell Biol 24 10515 10528 1:CAS:528: DC%2BD2cXhtFShu7bO 10.1128/MCB.24.24.10515-10528.2004 15572660 (Pubitemid 39603114)
25. M Tepel P Roerig M Wolter, et al. 2008 Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma Int J Cancer 123 2080 2086 1:CAS:528:DC%2BD1cXht1Chs7vN 10.1002/ijc.23705 18709645
26. XL Hu XP Liu SX Lin, et al. 2004 NDRG2 expression and mutation in human liver and pancreatic cancers World J Gastroenterol 10 3518 3521 1:CAS:528:DC%2BD2cXhtFCht7nF 15526377
27. DC Lee YK Kang WH Kim, et al. 2008 Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis Cancer Res 68 4210 4220 1:CAS:528:DC%2BD1cXmsFKmtb0%3D 10.1158/0008-5472.CAN-07-5040 18519680
28. K Taura S De Minicis E Seki, et al. 2008 Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis Gastroenterology 135 1729 1738 1:CAS:528:DC%2BD1cXhsVOhtbvL 10.1053/j.gastro.2008.07.065 18823985
29. T Tsujiuchi Y Sasaki Y Oka, et al. 2004 Alterations of the M6p/Igf2 receptor gene in hepatocellular carcinomas induced by Nnitrosodiethylamine and a choline-deficient L-amino acid-defined diet in rats Mol Carcinog 39 199 205 1:CAS:528:DC%2BD2cXjt1egur4%3D 10.1002/mc.20010 15057872 (Pubitemid 38452240)
30. O Gavrilova M Haluzik K Matsusue, et al. 2003 Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass J Biol Chem 278 34268 34276 1:CAS:528:DC%2BD3sXmvVCqsLw%3D 10.1074/jbc.M300043200 12805374 (Pubitemid 37553270)
31. ER Kallwitz A McLachlan SJ Cotler 2008 Role of peroxisome proliferator-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease World J Gastroenterol 14 22 28 1:CAS:528:DC%2BD1cXjsFykt78%3D 10.3748/wjg.14.22 18176957 (Pubitemid 351314322)